Skip to main content
. 2023 Dec 6;13:21557. doi: 10.1038/s41598-023-48493-8

Table 7.

Univariate and multivariable interval censored proportional hazards model regression estimates of relative risk of being confirmed negative for ZIKV in vaginal secretions.

Selected baseline factors Univariate model Multivariable model
Univariate HR (95% CI) Chi-sq p value Adjusted HR (95% CI) Chi-sq p value
Age group
 ≤ 35 1.00
 > 35 1.01 (0.74, 1.36) 0.97
Education level
 Secondary or lower 1.00
 Post-secondary 1.05 (0.76, 1.45) 0.78
BMI category (kg/m2)
 Normal weight (18.5–24.99) 1.00 1.00
 Overweight or obese (≥ 25.0) 0.75 (0.54, 1.05) 0.09 0.67 (0.48, 0.95) 0.026
Household members (excluding self)
 < 3 1.00
 ≥ 3 0.87 (0.63, 1.21) 0.40
Fever today or past 30 days
 (Yes vs No) 0.85 (0.58, 1.24) 0.39
Rash today or past 30 days*
 (Yes vs No) 1.79 (0.24, 13.4) 0.57
Pruritus today or past 30 days
 (Yes vs No) 0.71 (0.34, 1.49) 0.37
Non purulent conjunctivitis today or past 30 days
 (Yes vs No) 1.29 (0.92, 1.80) 0.14 1.46 (1.02, 2.10) 0.04
Joint pain today or past 30 days
 (Yes vs No) 1.38 (0.90, 2.10) 0.14
Periarticular edema today or past 30 days
 (Yes vs No) 0.80 (0.55, 1.16) 0.24
Yellow fever vaccination?
 (Yes vs No) 1.02 (0.57, 1.82) 0.96

HR > 1 implies a higher probability of being confirmed ZIKV RNA negative in vaginal secretions (lower likelihood of ZIKV persistence); HR < 1 implies a lower probability of being confirmed ZIKV RNA negative in vaginal secretions (increased likelihood of ZIKV persistence).

*Excluding 1 participant without rash.

ZIKV Zika virus, BMI body mass index, HR hazard ratio, CI confidence interval.